Haslam R J, Lynham J A, Fox J E
Biochem J. 1979 Feb 15;178(2):397-406. doi: 10.1042/bj1780397.
Human platelets that had been preincubated with 5-hydroxy[(3)H]tryptamine and [(32)P]P(i) were stirred with various agents; the secretion of 5-hydroxy[(3)H]tryptamine from platelet granules and the radioactivity of platelet [(32)P]phosphopolypeptides separated by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis were then measured. Exposure of the platelets to collagen fibres or ionophore A23187 selectively increased the phosphorylation of polypeptides with apparent mol.wts. of 47000 (P47) and 20000 (P20) by approx. 3-fold, in association with the release of 5-hydroxy[(3)H]tryptamine. The 47000-mol.wt. phosphopolypeptide (P47) was clearly separated from platelet actin by the electrophoresis system used. Prostaglandin E(1), which inhibits platelet function by increasing platelet cyclic AMP, decreased the phosphorylation of polypeptides caused by collagen as well as the release of 5-hydroxy[(3)H]tryptamine. Prostaglandin E(1) also selectively increased the phosphorylation of distinct polypeptides with apparent mol.wts. of 24000 (P24) and 22000 (P22) by approx. 2-fold. As the phosphorylation reactions caused by collagen are probably mediated by an increase in Ca(2+) concentration in the platelet cytosol and may have a role in the release reaction [Haslam & Lynham (1977) Biochem. Biophys. Res. Commun.77, 714-722; (1978) Thromb. Res.12, 619-628], we suggest that a cyclic AMP-dependent phosphorylation of the 24000- and/or 22000-mol.wt. polypeptides caused by prostaglandin E(1) may initiate processes that decrease the Ca(2+) concentration in the cytosol, so inhibiting both the Ca(2+)-dependent phosphorylation reactions and the release reaction. Treatment of platelets with prostaglandin E(1) did not inhibit the increased phosphorylation of polypeptides with apparent mol.wts. of 47000 and 20000 (P47 and P20) caused by ionophore A23187, which may therefore short-circuit cyclic AMP-dependent mechanisms that decrease the Ca(2+) concentration in the platelet cytosol. As prostaglandin E(1) did inhibit the release of 5-hydroxy[(3)H]tryptamine by ionophore A23187, cyclic AMP may also inhibit the release reaction by additional mechanisms.
将预先用5-羟基[³H]色胺和[³²P]无机磷酸预孵育的人血小板与各种试剂搅拌;然后测量血小板颗粒中5-羟基[³H]色胺的分泌以及通过十二烷基硫酸钠/聚丙烯酰胺凝胶电泳分离的血小板[³²P]磷酸化多肽的放射性。将血小板暴露于胶原纤维或离子载体A23187会选择性地使表观分子量为47000(P47)和20000(P20)的多肽的磷酸化增加约3倍,同时伴有5-羟基[³H]色胺的释放。在所用的电泳系统中,47000分子量的磷酸化多肽(P47)与血小板肌动蛋白明显分离。前列腺素E₁通过增加血小板环磷酸腺苷来抑制血小板功能,它可降低由胶原引起的多肽磷酸化以及5-羟基[³H]色胺的释放。前列腺素E₁还能使表观分子量为24000(P24)和22000(P22)的不同多肽的磷酸化选择性增加约2倍。由于胶原引起的磷酸化反应可能是由血小板胞质溶胶中钙离子浓度的增加介导的,并且可能在释放反应中起作用[哈斯拉姆和林厄姆(1977年)《生物化学与生物物理学研究通讯》77, 714 - 722;(1978年)《血栓形成研究》12, 619 - 628],我们认为前列腺素E₁引起的24000和/或22000分子量多肽的环磷酸腺苷依赖性磷酸化可能启动降低胞质溶胶中钙离子浓度的过程,从而抑制钙离子依赖性磷酸化反应和释放反应。用前列腺素E₁处理血小板并不抑制离子载体A23187引起的表观分子量为47000和20000(P47和P20)的多肽磷酸化增加,因此离子载体A23187可能绕过了降低血小板胞质溶胶中钙离子浓度的环磷酸腺苷依赖性机制。由于前列腺素E₁确实抑制了离子载体A23187引起的5-羟基[³H]色胺的释放,环磷酸腺苷也可能通过其他机制抑制释放反应。